[ Author] Title Type Year
Filters: Author is Oran, Betül [Clear All Filters]
Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2015.
Is there a role for therapy after transplant?. Best Pract Res Clin Haematol. 2015;28(2-3):124-132..
CheckPoint Inhibitors before and after Allogeneic Hematopoietic Stem Cell Transplant: The Double Edge Sword. Biol Blood Marrow Transplant. 2018..
Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors. Cancer. 2020.
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients. Blood Adv. 2020;4(21):5580-5588.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer. 2021.